explore -WSS

explore

author：focus 2025-09-28 02:27:50 - browse：54

Wraparound views of downtown Boston enrich the employees at the new offices of Foundation Medicine in the Seaport District. — Lane Turner/Globe Staff

Contemporary paintings by artists who have overcome homelessness or disabilities greet visitors in the lobby. Upstairs in the cafeteria, employees order lunches served by local restaurants, including barbecued pulled pork sandwiches from Pennypacker’s. On the top floor, workers can savor a panoramic view of the Seaport District and downtown Boston.

This is the new headquarters of Foundation Medicine, a biotechnology firm that is consolidating its 1,100 Massachusetts employees into a new 16-story brick masonry building at 400 Summer St. Foundation, established in 2010 and later acquired by the Swiss drug giant Roche, had workers scattered among four locations, including its former headquarters in Cambridge.

About 800 workers have moved into the 630,000-square-foot building, which is kitty-corner from the Boston Convention and Exhibition Center, with the remaining 300 expected to arrive by early next year. No one seems happier about the long-planned consolidation than Dan Malarek, a 17-year veteran of Roche who became Foundation’s chief executive in December.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： BIO selects John Crowley as new CEO

focus

leisure time

WSS

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

STAT Virtual Event: The State of Biosimilars: What to Watch

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Fetal surgery at risk from Dobbs and new abortion restrictions

Flagship Pioneering launches a new biotech in two countries

Why hospitals are withdrawing from US News rankings

Wikipedia

explore

Wikipedia

How to save PrEP access — and even expand it

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

FDA approval of Sarepta Duchenne genetic therapy gives me hope

UnitedHealth’s Optum accused of antitrust violations in California

In age of alternative facts, a scholarly course on calling out crap

Flagship Pioneering launches a new biotech in two countries

Medical records are filled with copy

WHO calls for emergency meeting on new China virus, as cases spread

Medical leaders decry Supreme Court decision on affirmative action

Flagship Pioneering launches a new biotech in two countries

focus

Cosmetics set for new safety regulation. Why the industry is on board

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

With clinical trial data readouts, here's how to spot spin

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Custom gene therapy hints at new path for rare disease treatments

Mayo Clinic plans $5B tech

focus

focus

leisure time

focus